Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study

Overview of attention for article published in Clinical, Cosmetic and Investigational Dermatology, September 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 758)
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 27 news outlets
blogs: 1 blog

twitter: 1 tweeter
patent: 2 patents

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 35 Mendeley

Summary News Blogs Twitter Patents Dimensions citations

So far, Dimensions has found 55 publications that cite this research output.

55

The most recent citing publications are shown below. View all 55 publications that cite this research output on Dimensions.

Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study

Article in Aesthetic Plastic Surgery (December 2022)

Sensory Symptoms Associated with Aesthetic Botulinum Toxin A Treatments

Article in Plastic & Reconstructive Surgery Global Open (November 2022)

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data

Article in Aesthetic Surgery Journal (August 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.